Pharmaceutical patents, prices and welfare losses: Policy options for India under the WTO TRIPS agreement

被引：35

作者：

Watal, J

机构：

[1] Inst. for International Economics, Washington, DC

[2] School of International Studies, Jawaharlal Nehru University, New Delhi

来源：

关键词：

D O I：

10.1111/1467-9701.00299

中图分类号：

F8 [财政、金融];

学科分类号：

0202 ;

摘要：

[No abstract available]

引用

页码：733 / 752

页数：20

共 22 条

[1]

[Anonymous], ANAL NEGOTIATING ISS

[2]

[Anonymous], WORLD COMPETITION

[3]

*BCG, 1996, SUST INN US PHARM IN

[4]

CAVES RE, 1991, BROOKINGS PAP ECO AC, P1

[5]

*CBO, 1998, INCR COMP GEN PHARM

[6] PRICE-COST MARGINS AND MARKET STRUCTURE [J].

COWLING, K ;

WATERSON, M .

[7]

Danzon P., 1997, PHARM PRICE REGULATI

[8]

DAVID S, 1998, INDIA TODAY 0720, P60

DIXIT, A ;

STERN, N .

[10]

FINK C, 1998, PATENT PROTECTION MU